Assignee
GAN & LEE PHARMACEUTICALS CO LTD
CN·1 granted patent·16 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
17 records- 0163US2025032589A1Insulin DerivativeGAN & LEE PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0255US2025011385A1Long-Acting GLP-1 CompoundGAN & LEE PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0353US12576136B2Insulin derivativeGAN & LEE PHARMACEUTICALS CO LTD·Filed 2020·Granted Mar 17, 2026·0 cites·43 claims
- 0452US2026055078A1Compound functioning as smarca2/4 inhibitor and use thereofGAN & LEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0551US2025228919A1Insulin DerivativeGAN & LEE PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0650US2025332167A1Pharmaceutical use of cdk 4/6 inhibitorGAN & LEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0750US2025129088A1Cereblon e3 ubiquitin ligase inhibitorGAN & LEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0847US2025026815A1Anti-rsv antibody and application thereofGAN & LEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0947US2024316157A1Pharmaceutical composition of pcsk9 inhibitor and glp-1 receptor agonistGAN & LEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1046US2025276043A1Pharmaceutical Composition Containing GLP-1 CompoundGAN & LEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1146US2025161473A1Exatecan derivative-antibody conjugate and medical use thereofGAN & LEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1244US2025340610A1Acylated insulinGAN & LEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1343US2025262282A1Acylated Insulin-Containing Pharmaceutical CompositionGAN & LEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1442US2022168302A1Salts of a compound, crystal forms of the salts and preparation method and use thereofGAN & LEE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1542US2024239859A1Long-Acting GLP-1 CompoundGAN & LEE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1639US2022315532A1Methods for preparing cdk4/6 inhibitor and salt and intermediate thereofGAN & LEE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1737US2022298240A1Bispecific Chimeric Antigen ReceptorGAN & LEE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GAN & LEE PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →